Heslop, Helen E.,Straathof, Karin,Gottschalk, Stephen M.g.,Rooney, Cliona M.,Louis, Chrystal U.,Brenner, Malcolm K.
申请号:
AU2011295845
公开号:
AU2011295845B2
申请日:
2011.09.01
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The present invention concerns methods and compositions for treatment of locoregional nasopharyngeal carcinoma utilizing EBV- specific T cells. In specific embodiments, locoregional solid tumors are treated with cytotoxic T lymphocytes specific for at least one EBV antigen, such as LMP2, LMPl, and/or EBNAl, for example.